Sign in

You're signed outSign in or to get full access.

Eric West

Chief Financial Officer at Aqua MetalsAqua Metals
Executive

About Eric West

Eric West is Chief Financial Officer of Aqua Metals (AQMS), appointed May 7, 2025 and effective May 19, 2025. He previously held finance roles at Aqua Metals from 2019–Nov 2024 (most recently VP Finance), spent Nov 2024–May 2025 as VP of Finance & Accounting at a private company, began his career at Grant Thornton, and holds a Master of Accountancy from the University of Nevada, Reno; he is a licensed CPA. He is 34 years old. Company compensation practices emphasize “SMART” annual objectives (STIP) and three‑year RSU‑based LTIP; company TSR declined 39% in 2023 and 59% in 2024, contextualizing a challenging backdrop prior to his appointment .

Past Roles

OrganizationRoleYearsStrategic impact
Aqua Metals, Inc.Chief Financial OfficerAppointed May 7, 2025; effective May 19, 2025 Finance leadership, public company CFO responsibilities
Aqua Metals, Inc.VP Finance; other finance roles2019 – Nov 2024 Progressively senior finance roles; internal continuity
Private company (undisclosed)VP Finance & AccountingNov 2024 – May 2025 External finance leadership role
Grant Thornton, LLPEarly careerNot disclosed Public accounting foundation; licensed CPA

Fixed Compensation

ComponentTerms
Base salary$300,000 annual rate under CFO employment agreement (May 2025)
Benefits“Reasonable and customary” health and other benefits at company expense

Performance Compensation

Short-Term Incentive Plan (STIP)

ItemDetails
Target opportunityUp to 75% of base salary
Metrics frameworkBoard-approved annual “SMART” objectives; objective, measurable, rigorous
Payout formulaYear-end rating (1–5) × target bonus
Payout formCash or RSUs at Compensation Committee discretion

Long-Term Incentive Plan (LTIP) and Equity Awards

ItemDetails
Target opportunityUp to 125% of base salary; LTIP payable in RSUs
2019 Stock Incentive PlanGoverns options/RSUs/PSUs; contains broad performance criteria including EBITDA, TSR, stock price, revenue, etc.
Initial CFO equity grantRSUs for 100,000 shares, vesting over three years from grant date
Valuation contextRSU package disclosed at $98,000 fair value and 100,000 units (approved subject to plan amendment)
Share reserve and overhang2019 Plan share increase of 2,600,000 (to 4,000,000); ~28% of 9,446,105 shares outstanding as of June 5, 2025; closing price $0.73 on June 5, 2025
Shareholder approval statusPlan share increase approved July 22, 2025

Notes:

  • For other NEOs, the company has used TSR- and stock‑price‑hurdle PSUs; West’s disclosed LTIP is RSU‑based (time vesting) with no PSUs specifically disclosed for him .

Equity Ownership & Alignment

ItemDetails
Beneficial ownership (June 5, 2025)1,250 shares; less than 1% of outstanding
Unvested awards100,000 RSUs (3‑year vesting); subject to and now within amended 2019 Plan capacity
Hedging/pledgingInsider Trading Policy prohibits short sales, publicly traded options, hedging, margin and pledged securities
ClawbackExecutive Officer Clawback Policy adopted to comply with SEC Rule 10D‑1/Nasdaq 5608; 3‑year lookback on erroneously awarded incentive compensation
Ownership guidelinesProxy discloses director stock ownership guideline (3× cash board fee); no separate officer ownership guideline described in this filing

Employment Terms

TermDetails
Appointment/effective dateAppointed CFO May 7, 2025; effective May 19, 2025
Base salary$300,000
STIP targetUp to 75% of base salary; cash or RSUs
LTIP targetUp to 125% of base salary; payable in RSUs
Severance (no cause/good reason)12 months’ base salary plus pro‑rata STIP and LTIP for year of termination (assuming full performance achievement)
Change‑of‑control termsNo enhanced CoC multiple/acceleration disclosed for West in the 8‑K
IP/confidentialityCustomary assignment and confidentiality provisions

Compensation Structure Analysis

  • Mix and leverage: West’s pay design skews heavily to at‑risk compensation via a 75% STIP and 125% LTIP, aligning outcomes with annual objectives and multi‑year equity value but primarily through time‑vested RSUs (lower risk than PSUs) .
  • Plan capacity and dilution: The 2019 Plan share pool increase (2.6M shares, ~28% of outstanding) was sought to fund RSU grants including West’s 100,000 units; shareholders approved the increase on July 22, 2025, mitigating issuance risk but elevating dilution overhang .
  • Governance: Compensation Committee engaged Pay Governance LLC in 2024 to review executive compensation, severance, and STIP/LTIP structure; company maintains a clawback and prohibits hedging/pledging, supporting governance quality .

Say-on-Pay & Shareholder Feedback

  • 2025 say‑on‑pay approved: For 1,629,971; Against 569,042; Abstain 101,034 (broker non‑votes 2,684,708) .
  • 2019 Plan amendment (share increase) approved the same meeting, enabling outstanding RSU approvals to proceed .

Performance & Track Record (Context)

  • Company “compensation actually paid” trended down alongside TSR declines: CEO CAP fell to $869,740 in 2024 from $1,447,590 in 2023; TSR decreased 39% (2022→2023) and 59% (2023→2024); net loss increased 55% (2022→2023) and 2% (2023→2024), framing a challenging environment preceding West’s appointment .

Investment Implications

  • Alignment vs. pressure: West’s initial 100,000 RSUs (3‑year vesting) create long‑term alignment but also a known vesting cadence that can add incremental supply over time; hedging/pledging prohibitions and a clawback policy are positives for alignment and downside governance risk .
  • Retention and cost on exit: Severance of 12 months’ salary plus pro‑rata STIP/LTIP is moderate for a small‑cap, balancing retention with cost discipline; no disclosed change‑of‑control uplift reduces parachute risk but may modestly increase retention risk in M&A scenarios .
  • Pay‑for‑performance signal: Heavy at‑risk targets (75% STIP/125% LTIP) and board‑approved “SMART” goals emphasize execution; the company’s recent TSR/net loss trends set a low base for improvement but also heighten execution risk in the near term .
  • Dilution overhang: The 2019 Plan expansion (2.6M shares) supports talent retention and equity‑based pay but increases dilution; investors should monitor grant pacing and vesting outcomes, including West’s RSUs, against value creation milestones .